InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the detailed record of transactions filed by Godwin Mary E.. Officer active across 1 company, notably Nautilus Biotechnology, Inc.. In total, 2 reports have been recorded. History available since 17 September 2024. The latest transaction was disclosed on 23 September 2024 (Levée d'options). Regulator: SEC (Form 4). All data is free.
2 of 2 declarations